E-Learning

On Friday, Mersana Therapeutics Inc. (NASDAQ:MRSN) released initial data from the Phase 1 dose escalation and backfill cohorts for emiltatug ledadotin. Emi-Le was generally well tolerated, with no Grade 4 or 5 treatment-related adverse events reported. At intermediate doses in the trial (38.1 mg/m2 to 67.4 mg/m2), the confirmed objective response rate among evaluable patients was 23% (6 of 26 patients) across all B7-H4 high tumors and 23% (3 of 13 patients) with B7-H4 high TNBC, all of whom had

Constellation Brands shares plunged Friday, after the maker of beer, wine, and spirits cut its guidance as consumers held back spending.

The long-struggling chain reported better-than-expected revenue for its Q1 2025, although operating losses grew as it plans to shutter over a thousand locations.

On Friday, Invivyd Inc. (NASDAQ:IVVD) announced that new in vitro neutralization data show continued neutralizing activity of Pemgarda (pemivibart) and pipeline candidate VYD2311 against dominant SARS-CoV-2 variant XEC. The stock is trading with a strong session volume of 12.3 million, compared to an average volume of 757.02k as per data from Benzinga Pro. As anticipated, the data are largely consistent with those previously reported for KP.3.1.1, based on the structural biology of pemivibart an

(Bloomberg) -- A hectic week for UK bond and currency traders came to an end with yields stuck near the highest levels in years and the pound at its weakest since late 2023.Most Read from BloombergWhat Robotaxis Brought San FranciscoA Blueprint for Better Bike LanesNYC Condo Owners May Bear Costs of Landmark Green Building LawAmbitious High-Speed Rail Plans Advance in the Baltic RegionNYC’s Subway Violence Deters Drive to Bring Workers Back to OfficeGilts and sterling fell again on Friday after

U.S. equities slumped at midday after the December jobs report came in higher than anticipated, putting more Federal Reserve rate cuts in doubt.

Constellation Energy shares surged Friday after the company agreed to buy private energy company Calpine in a deal valued at $26.6 billion.

Caution reigns ahead of December's jobs report, which will shape bets on the chances of Fed rate cuts.

Delta Q4 results landed above expectations, boosted by corporate and international travel demand

These 10 stocks have the highest dividend yields in the Dow.